Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
US-12227479-B2 · Feb 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ohlmeyer Michael patents
Ohlmeyer Michael is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ohlmeyer Michael |
| Total patents | 26 |
| First publication | Aug 13, 2015 |
| Latest publication | Feb 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
US-2023095139-A1 · Mar 30, 2023 · US
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
US-11512052-B2 · Nov 29, 2022 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-10759790-B2 · Sep 1, 2020 · US
Compositions and methods for treating cancer
US-10744141-B2 · Aug 18, 2020 · US
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols
US-10450282-B2 · Oct 22, 2019 · US
Cyclic vinylogous amides as bromodomain inhibitors
US-10351511-B2 · Jul 16, 2019 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-10221158-B2 · Mar 5, 2019 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-2018251444-A1 · Sep 6, 2018 · US
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
US-2018251456-A1 · Sep 6, 2018 · US
Recent patents
Latest publications not already listed above.
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols
US-2018230112-A1 · Aug 16, 2018 · US
Compositions and methods for treating cancer
US-2018185382-A1 · Jul 5, 2018 · US
Cyclic vinylogous amides as bromodomain inhibitors
US-2018105485-A1 · Apr 19, 2018 · US
Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents
US-9937186-B2 · Apr 10, 2018 · US
Constrained tricyclic sulfonamides
US-9937180-B2 · Apr 10, 2018 · US
Cyclic vinylogous amides as bromodomain inhibitors
US-9884806-B2 · Feb 6, 2018 · US
Tricyclic heterocycles as anticancer agents
US-2018002339-A1 · Jan 4, 2018 · US
Tricyclic heterocycles as anticancer agents
US-9796717-B2 · Oct 24, 2017 · US
Constrained tricyclic sulfonamides
US-2017015630-A1 · Jan 19, 2017 · US
Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents
US-2017015625-A1 · Jan 19, 2017 · US
Tricyclic compounds as anticancer agents
US-9540358-B2 · Jan 10, 2017 · US
Method and compositions for treating cancer and related methods
US-9494572-B2 · Nov 15, 2016 · US
Cyclic vinylogous amides as bromodomain inhibitors
US-2016200666-A1 · Jul 14, 2016 · US
Tricyclic heterocycles as anticancer agents
US-2015376191-A1 · Dec 31, 2015 · US
Method and compositions for treating cancer and related methods
US-9134297-B2 · Sep 15, 2015 · US
Method and Compositions for Treating Cancer and Related Methods
US-2015224101-A1 · Aug 13, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Icahn School Med Mount Sinai | 26 |
| Ichan School Of Medicine At Mount Sinai | 3 |
| Us Gov Veterans Affairs | 2 |
| Narla Goutham | 2 |
| Ohlmeyer Michael | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 21 |
| A61K31/517 | 14 |
| A61P25/28 | 13 |
| A61K31/55 | 12 |
| A61P37/06 | 10 |